Latest Breaking News On - Health research framework program - Page 1 : comparemela.com

After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year

EQS-News: aap Implantate AG / Key word: Interim Report/Corporate Action After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year 15.02.2024.

Standard of the frankfurt stock exchangeHealth research framework programImplants incGerman federal ministry of educationNotified bodyGerman federal ministryHealth research frameworkRegulated marketGerman stock exchangesGeneral standardFrankfurt stock exchangeManagement boardRubino di girolamo

EQS-News: After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year

EQS-News: After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

German federal ministry of educationImplants incHealth research framework programStandard of the frankfurt stock exchangeNotified bodyGerman federal ministryHealth research frameworkRegulated marketGerman stock exchangesGeneral standardFrankfurt stock exchangeManagement boardRubino di girolamo

More than 100 patients included in the human clinical trial by 31 December 2023; adapted study desig

EQS-Media / 10.01.2024 / 07:30 CET/CESTWith regard to its innovative antibacterial implant technology, aap was able to successfully accelerate recruitment in the ongoing human clinical trial with the adapted study design in the course of 2023 and has already successfully recruited more than 100 patients by 31 Decemb.

United statesImplants incDistribution servicesMinistry of educationFrankfurt stock exchangeHealth research framework programFederal ministryResearch framework programRegulated marketGeneral standardExecutive boardRubino di girolamoPress releaseRegulatory announcementsCorporate news

More than 100 patients included in the human clinical trial by 31 December 2023; adapted study design meets expectations for accelerated patient recruitment

EQS-Media / 10.01.2024 / 07:30 CET/CEST With regard to its innovative antibacterial implant technology, aap was able to successfully accelerate recruitment in the ongoing human clinical trial.

United statesFrankfurt stock exchangeMinistry of educationImplants incHealth research framework programFederal ministryResearch framework programRegulated marketGeneral standardExecutive boardRubino di girolamo

Visible acceleration in clinical trial with already more than 60 patients; increase in funding of around EUR 0 4 million underscores innovative strength of silver coating technology

EQS-News: aap Implantate AG / Key word: Study Visible acceleration in clinical trial with already more than 60 patients; increase in funding of around EUR 0.4 million.

United statesMarek hahnGerman federal ministry of educationStandard of the frankfurt stock exchangeHealth research framework programImplants incGerman federal ministryHealth research frameworkRegulated marketGerman stock exchangesGeneral standardFrankfurt stock exchangeManagement board